In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials ...

Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...

Having got off to a strong start to the year the UK economy is expected to slow in the second half of this year. In Q1 we saw the economy achieve growth of 0.6%, before slowing modestly to 0.5% in Q2, ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

AstraZeneca is building a US$1.5 billion manufacturing facility in Tuas South, Singapore, which will create over 800 jobs.

AstraZeneca plans to hire over 800 in Singapore for engineering, quality, technical services, and supply chain roles at its ...

Chinese authorities detained the head of AstraZeneca’s China business last week, a move that threatens to dim foreign ...

Pharmaceutical giant AstraZeneca has confirmed that Leon Wang, the head of its China operations, had been detained.